Compare Organon & Co. Common Stock (OGN) vs United Parcel Service Inc (UPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs United Parcel Service Inc — how do they compare? Organon & Co. Common Stock trades at $13.77 (market cap $3.61B), while United Parcel Service Inc trades at $98.06 (market cap $81.49B). The key difference: United Parcel Service Inc is far larger — about 22.6× Organon & Co. Common Stock's market cap, and United Parcel Service Inc pays the higher dividend (6.85%). Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and United Parcel Service Inc for 141 Days on average.
| OGN | UPS | |
|---|---|---|
Market Cap | $3.61B | $81.49B |
Volume | 1,808,049 | 3,142,170 |
Sector | Health | Industrials |
52-Week High | $13.81 | $120.00 |
52-Week Low | $5.70 | $84.09 |
Typical Hold Time | 0 Days | 141 Days |
Enterprise Value | $11.03B | $105.51B |
Dividend Yield | 0.58% | 6.85% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
UPS trades at $94.76, down 0.61% on the day, with a bullish technical signal despite mixed moving averages and oscillators. The company shows solid profitability with a 5.08% net margin and 29.66% ROE, though revenue has declined from $100.3B in 2022 to $88.66B in 2025. Recent news highlights UPS's new Secure Commerce platform and an exclusive TikTok Shop returns deal, aiming to bolster e-commerce services amid competitive pressures.
The stock presents a value opportunity with a P/E of 17.8 below industry averages and a consensus price target of $118.67 implying 25% upside. However, risks include declining package volumes, margin pressure from fuel costs, and stiff competition from Amazon. Analyst sentiment is mixed with 47% buy ratings, but Bank of America recently downgraded to sell on volume concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
